TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T01301 XX ID T01301 XX DT 21.10.1994 (created); ewi. CO Copyright (C), QIAGEN. XX FA E4 XX SY E4; E4-ORF6/7. XX OS adenovirus type 2 OC viridae; ds-DNA nonenveloped viruses; adenoviridae XX SZ 153 AA; 17.4 kDa (gene) (calc.). XX SQ MTTSGVPFGMTLRPTRSRLSRRTPYSRDRLPPFETETRATILEDHPLLPECNTLTMHNVS SQ YAWTSPSPPVEQPQVGQQPVAQQLDSDMNLSELPGEFINITDERLARQETVWNITPKNMS SQ VTHDMMLFKASRGERTVYSVCWEGGGRLNTRVL XX SC Swiss-Prot#P03238 XX FF largely enhances (activates) E2F binding to a E2F binding site (inverted repeat); XX IN T01543 E2F-1; mouse, Mus musculus. IN T00221 E2F:DP; human, Homo sapiens. XX BS R03879. XX DR TRANSPATH: MO000025565. DR EMBL: J01917; DR UniProtKB: P03238; XX RN [1]; RE0002225. RX PUBMED: 1836562. RA O'Connor R. J., Hearing P. RT The C-terminal 70 amino acids of the adenovirus E4-ORF6/7 protein are essential and sufficient for E2F complex formation RL Nucleic Acids Res. 19:6579-6586 (1991). XX //